In our previous study, we reported that blockade of IL-6 trans-signaling could attenuate peritoneal fibrosis by inhibiting the activation of Smad2/3, with reduced expressions of α-smooth muscle actin (α-SMA) and collagen type I (Col I) in a mouse model (61). The gene discussed is SMAD2; the disease is Peritoneal Fibrosis.